Fig 7. Risk of P. vivax parasitaemia following falciparum infection between day 7 and day 42 according to treatment.
Dotted lines demonstrate 95% CIs. Figure adjusted for age, sex, baseline parasitaemia, regional relapse periodicity, P. falciparum gametocytes, mixed infection, and baseline Hb, assuming no study-site effect. AA, artesunate-amodiaquine; AL, artemether-lumefantrine; AM, artesunate-mefloquine; DP, dihydroartemisinin-piperaquine; Hb, haemoglobin.
